Search Results

Showing results 271 - 280 for leonard

Publications | Page 2 | Cerchietti Research Lab

... A, Wehrli NE, van Besien K, Martin P, Furman RR, Leonard JP, Cerchietti L.  2017.  The eIF4E inhibitor...

https://cerchiettilab.weill.cornell.edu/publications?page=1&s=type&o=asc

Publications | Page 3 | Cerchietti Research Lab

... RL, Yang SNing, Taldone T, Chang B, Gerecitano J, Elenitoba-Johnson K, Shaknovich R, Tam W, Leonard...

https://cerchiettilab.weill.cornell.edu/publications?page=2

Dose Escalation and Expansion Study: Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and Combined with Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Relapsed or Refractory B-Cell Malignancies | Joint Clinical Trials Office

...) 746-1362 Primary Investigator John Leonard, M.D. Protocol ID(s) Weill Cornell Medicine IRB...

https://jcto.weill.cornell.edu/open_clinical_trials/dose-escalation-and-expansion-study-safety-tolerability-and-efficacy-of-anti-lag-3-monoclonal-antibody-bms-986016-administered-alone-and-combined-with-anti-pd-1-monoclonal-antibody-nivolumab-bms-936558-in-relapsed-or-refractory-b-cell

Marfan: 2018 Walk for Victory - Weill Cornell Medicine Events

... will be your team!! Led by Walk for Victory chair Dr. Leonard N. Girardi, funds raised through...

http://events.weill.cornell.edu/event/marfan_2018_walk_for_victoru

Obinutuzumab vs. rituximab weighed as follicular lymphoma therapy | Sandra and Edward Meyer Cancer Center

... of a story from Hematology News. Read the full article here. Dr. John Leonard Does obinutuzumab have...

https://meyercancer.weill.cornell.edu/news/2017-04-18/obinutuzumab-vs-rituximab-weighed-follicular-lymphoma-therapy

David Epstein’s Flight Back to Health at Weill Cornell | Patient Care

... lots of research, they found Dr. Leonard Girardi at Weill Cornell Medicine. “When I learned that Dr...

https://weillcornell.org/news/david-epstein%E2%80%99s-flight-back-to-health-at-weill-cornell

How patients can benefit from clinical trials | Sandra and Edward Meyer Cancer Center

.... These trials are FDA approved and monitored by an independent ethics group. Dr. John Leonard (Twitter...

https://meyercancer.weill.cornell.edu/news/2015-04-20/how-patients-can-benefit-clinical-trials

nyc_marfan_2018.pdf

... and nonsurgical treatment of pediatric spinal Dr. Leonard N. Girardi, Chairman of the Department...

https://ctsurgery.weillcornell.org/sites/default/files/nyc_marfan_2018.pdf

Rituximab Plus Lenalidomide More Effective Against Indolent Lymphoma Than Rituximab Alone | Newsroom | Weill Cornell Medicine

..., 2019 Share to Facebook Share to Twitter Share to LinkedIn Share on Email Dr. John Leonard. Credit...

https://news.weill.cornell.edu/news/2019/05/rituximab-plus-lenalidomide-more-effective-against-indolent-lymphoma-than-rituximab

Person

... Leonard, Garrick H Assistant Professor of Clinical Obstetrics and Gynecology Leonard, John P Senior...

http://vivo.med.cornell.edu/individuallist?page=156&vclassId=http%3A%2F%2Fxmlns.com%2Ffoaf%2F0.1%2FPerson

Showing results 271 - 280 for leonard